Evaluation of Elemental Impurities in Drugs and Drug Products ICH Q3D(R2)
1:20:46
FDA Expectations on Controlling Nitrosamine Impurities in Human Drugs
26:22
Learning from FDA Citations - Sanitation and Maintenance
20:38
Residual Solvents and Elemental Impurities: Classification & Exposure Limits as per ICH Q3C AND Q3D
11:11
KPI de qualidade
26:37
Investigations – Do you really comply?
39:20
Overcoming Top Seven Reasons for Digitalization in Pharmaceuticals
51:27
How to Validate Computerized GxP Systems in the Life Sciences 11 08 16
18:01